Literature DB >> 16024189

Improved physicochemical characteristics of felodipine solid dispersion particles by supercritical anti-solvent precipitation process.

Dong-Han Won1, Min-Soo Kim, Sibeum Lee, Jeong-Sook Park, Sung-Joo Hwang.   

Abstract

Solid dispersions of felodipine were formulated with HPMC and surfactants by the conventional solvent evaporation (CSE) and supercritical anti-solvent precipitation (SAS) methods. The solid dispersion particles were characterized by particle size, zeta potential, scanning electron microscopy (SEM), differential scanning calorimetry (DSC), powder X-ray diffraction (XRD), solubility and dissolution studies. The effects of the drug/polymer ratio and surfactants on the solubility of felodipine were also studied. The mean particle size of the solid dispersions was 200-250 nm; these had a relatively regular spherical shape with a narrow size distribution. The particle size of the solid dispersions from the CSE method increased at 1 h after dispersed in distilled water. However, the particle sizes of solid dispersions from the SAS process were maintained for 6 h due to the increased solubility of felodipine. The physical state of felodipine changed from crystalline to amorphous during the CSE and SAS processes, confirmed by DSC/XRD data. The equilibrium solubility of the felodipine solid dispersion prepared by the SAS process was 1.5-20 microg/ml, while the maximum solubility was 35-110 microg/ml. Moreover, the solubility of felodipine increased with decreasing drug/polymer ratio or increasing HCO-60 content. The solid dispersions from the SAS process showed a high dissolution rate of over 90% within 2 h. The SAS process system may be used to enhance solubility or to produce oral dosage forms with high dissolution rate.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16024189     DOI: 10.1016/j.ijpharm.2005.05.017

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  18 in total

Review 1.  Amorphous solid dispersion technique for improved drug delivery: basics to clinical applications.

Authors:  Dinesh Kumar Mishra; Vinod Dhote; Arpit Bhargava; Dinesh Kumar Jain; Pradyumna Kumar Mishra
Journal:  Drug Deliv Transl Res       Date:  2015-12       Impact factor: 4.617

2.  Solid Dispersion of Curcumin as Polymeric Films for Bioenhancement and Improved Therapy of Rheumatoid Arthritis.

Authors:  Prashant P Mande; Sagar S Bachhav; Padma V Devarajan
Journal:  Pharm Res       Date:  2016-05-31       Impact factor: 4.200

3.  Assessment of improved buccal permeation and bioavailability of felodipine microemulsion-based cross-linked polycarbophil gel.

Authors:  Mahendra Singh; Jovita Kanoujia; Poonam Parashar; Malti Arya; Chandra B Tripathi; V R Sinha; Shailendra K Saraf; Shubhini A Saraf
Journal:  Drug Deliv Transl Res       Date:  2018-06       Impact factor: 4.617

4.  Application of pharmaceutical QbD for enhancement of the solubility and dissolution of a class II BCS drug using polymeric surfactants and crystallization inhibitors: development of controlled-release tablets.

Authors:  Emad B Basalious; Wessam El-Sebaie; Omaima El-Gazayerly
Journal:  AAPS PharmSciTech       Date:  2011-06-24       Impact factor: 3.246

5.  A menthol-based solid dispersion technique for enhanced solubility and dissolution of sulfamethoxazole from an oral tablet matrix.

Authors:  Bibi F Choonara; Yahya E Choonara; Pradeep Kumar; Lisa C du Toit; Lomas K Tomar; Charu Tyagi; Viness Pillay
Journal:  AAPS PharmSciTech       Date:  2014-12-31       Impact factor: 3.246

6.  Preparation and in vitro/in vivo evaluation of felodipine nanosuspension.

Authors:  Bhanu P Sahu; Malay K Das
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2013-11-07       Impact factor: 2.441

7.  Development of a Sustained Release Solid Dispersion Using Swellable Polymer by Melting Method.

Authors:  Tuong Ngoc-Gia Nguyen; Phuong Ha-Lien Tran; Toi Van Vo; Wei Duan; Thao Truong-Dinh Tran
Journal:  Pharm Res       Date:  2015-08-12       Impact factor: 4.200

8.  Extended release felodipine self-nanoemulsifying system.

Authors:  Pradeep R Patil; Shailesh V Biradar; Anant R Paradkar
Journal:  AAPS PharmSciTech       Date:  2009-05-05       Impact factor: 3.246

9.  3-Ethyl 5-methyl 4-(2,3-dichloro-phen-yl)-2,6-dimethyl-pyridine-3,5-dicarboxyl-ate.

Authors:  Jing Luo; Hui Chen; Qiao-Feng Wang; Hai-Jing Liu
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-02-06

10.  Enhanced bioavailability of sirolimus via preparation of solid dispersion nanoparticles using a supercritical antisolvent process.

Authors:  Min-Soo Kim; Jeong-Soo Kim; Hee Jun Park; Won Kyung Cho; Kwang-Ho Cha; Sung-Joo Hwang
Journal:  Int J Nanomedicine       Date:  2011-11-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.